Buyer for a healthcare software company in Europe

• Revenue: 2-100 million EUR
• Employees: Not a decisive factor
• Location of the target: Europe
• Reason for acquisition: The company is a large healthcare software company. It has a strategy for growing its operations in Europe via acquisitions, therefore the management is open to speaking to interested sellers
• #CFIE ITB057

The company is active in developing and delivering software solutions for healthcare organizations and their patients. The buyer is a global provider with offices in the US, Canada, Europe, Latin America, the Asia Pacific countries and Japan. The company has extensive experience in the field and has more than 10 000 employees worldwide. As part of the group’s growth strategy, the management team has established the main goal of expanding operations by acquiring another company that has the same activity and develop compatible products with similar technology. The buyer has an important record of acquisitions and has allocated new funds for more transactions. The target company needs to have good exposure to the European healthcare industry and should demonstrate a high potential for growth.

The buyer company is a large player in the healthcare software market, the main activity consists of creating software solutions that help life sciences companies to bring more innovation to their activity, to take advantage of their opportunities and to further develop human health. To achieve this goal, the software company has combined data science and human science and the result is that various illnesses are prevented and treated more effectively. In order to receive critical answers about human health, it is necessary as the first step that the data is collected, studied, identified and protected. Afterward, through software solutions, this data is linked to advanced analytics, and is technologically transformed using specific domain expertise in order to bring a new approach for clinical development to healthcare customers.

The company uses its 4 business core pillars such as domain expertise, unparalleled data, advanced analytics and transformative technology in order to create solutions that streamline healthcare centers activity. To achieve domain expertise, the company gathers domain experts, technology experts, data scientists and statisticians, epidemiologists, medical doctors, and service experts. This assists in having knowledge and expertise across diseases, geographies and scientific methods. To gather enough unparalleled data, the company has access to extensive resources and collects data from countries, institutions, physicians, investigators, social media, healthcare professionals, etc. Advanced analytics such as analytics engines and re-usable algorithms help in achieving a more precise decision-making process for healthcare players. Transformative technologies are used for obtaining critical information. These technologies such as integrated analytics, multi-channel marketing, social listening, visualization, workflow automation, and user experience components help in integrating the information into the same system for better management of information. One of the benefits of using human data science is, aside from disease prevention and treatment, finding patients with rare diseases by identifying subtle patterns. The company’s solutions can be used in developing treatments that provide the best conditions for the patients.

The buyer is looking to acquire a company that develops healthcare software solutions usable in:

• Research and development
• Content and data management
• Predictive analytics
• Safety
• Health economics
• Commercial data warehouse
• Digital governance
• Territory management
• Site payments
• Commercialization
• Therapeutic areas

• The buyer is a software solution developer that operates in the healthcare sector
• The company creates healthcare software solutions to increase efficiency
• The company has decided to enlarge its activities in Europe and is looking to buy another company with similar activities
• Target companies should have good exposure to the European healthcare industry and should demonstrate a high potential for growth